One year clinical follow-up of the XIENCE V Everolimus-eluting stent system in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II study-Reference-Cited by-同舟云学术

One year clinical follow-up of the XIENCE V Everolimus-eluting stent system in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II study

Published:2007-11 Issue:3 Volume:3 Page:315-320
ISSN:1774-024X
Container-title:EuroIntervention
language:
Short-container-title:EuroIntervention

Author:

Ruygrok Peter,Desaga Martin,Van Den Branden Franck,Rasmussen Klaus,Suryapranata Harry,Dorange Cécile,Veldhof Susan,Serruys Patrick

Publisher

Europa Digital & Publishing

Subject

Cardiology and Cardiovascular Medicine

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Clinical Performance of Biodegradable Polymer-Coated Ultra-Thin Everolimus-Eluting Stents in “Real-World” Patients: A Multicenter Registry (PERFORM-EVER);The Anatolian Journal of Cardiology;2022-07-29

2. Real-World Long-Term Clinical Outcomes of Ultrathin Strut Biodegradable Polymer Drug-Eluting Stents in Korean ST-Segment-Elevation Myocardial Infarction (STEMI) Patients with or without Acute Heart Failure Undergoing Primary Percutaneous Coronary Intervention;Journal of Clinical Medicine;2021-12-15

3. Second generation drug-eluting stents: a focus on safety and efficacy of current devices;Expert Review of Cardiovascular Therapy;2021-02-01

4. Device profile of the XIENCE V and XIENCE Sierra stents for the treatment of coronary artery disease: an overview of safety and efficacy;Expert Review of Medical Devices;2020-04-10

5. Nitric oxide releasing poly(vinylidene fluoride-co-hexafluoropropylene) films using a fluorinated nitric oxide donor to greatly decrease chemical leaching;Acta Biomaterialia;2019-05